Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Ligand Binding Sites02:40

Ligand Binding Sites

12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

13.0K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
13.0K
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

233
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
233
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

583
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
583
Protein-protein Interfaces02:04

Protein-protein Interfaces

12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

3.1K
3.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

HEroBM: A deep equivariant graph neural network for high-fidelity backmapping from coarse-grained to all-atom structures.

The Journal of chemical physics·2025
Same author

PLUMED Tutorials: A collaborative, community-driven learning ecosystem.

The Journal of chemical physics·2025
Same author

Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery.

Nature reviews. Drug discovery·2025
Same author

Correction to "Discovery of a Novel Class of Dual GPBAR1 Agonists-RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders".

ACS omega·2023
Same author

Conformational plasticity and allosteric communication networks explain Shelterin protein TPP1 binding to human telomerase.

Communications chemistry·2023
Same author

Structural basis of dimerization of chemokine receptors CCR5 and CXCR4.

Nature communications·2023

相关实验视频

Updated: Jul 17, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.6K

关于联体/蛋白质结合动力学模拟的观点:力场,机器学习,采样和用户友好性.

Paolo Conflitti1, Stefano Raniolo1, Vittorio Limongelli1,2

  • 1Faculty of Biomedical Sciences, Euler Institute, Universitá della Svizzera italiana (USI), 6900 Lugano, Switzerland.

Journal of chemical theory and computation
|September 1, 2023
PubMed
概括

计算药物发现通过过候选药物来加速临床前研究. 本综述探讨了连接体/蛋白质结合动力学,强调了先进的技术和更准确的药物设计的未来方向.

更多相关视频

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

322
Analyzing Protein Architectures and Protein-Ligand Complexes by Integrative Structural Mass Spectrometry
07:33

Analyzing Protein Architectures and Protein-Ligand Complexes by Integrative Structural Mass Spectrometry

Published on: October 15, 2018

14.3K

相关实验视频

Last Updated: Jul 17, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.6K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

322
Analyzing Protein Architectures and Protein-Ligand Complexes by Integrative Structural Mass Spectrometry
07:33

Analyzing Protein Architectures and Protein-Ligand Complexes by Integrative Structural Mass Spectrometry

Published on: October 15, 2018

14.3K

科学领域:

  • 计算化学是一种计算化学.
  • 药理学 药理学是指药理学的学科.
  • 生物物理学的生物物理.

背景情况:

  • 计算药物发现有助于识别活性化合物,降低成本和时间.
  • 从历史上看,人们一直关注稳定的药物标复合体的高亲缘关系联体.
  • 新兴的研究将体内药物疗效与结合动力学联系起来,需要动力学模拟.

研究的目的:

  • 在药物发现中审查联体/蛋白结合动态模拟技术的现状.
  • 评估现有方法的局限性.
  • 为开发更准确的运动模型提出解决方案.

主要方法:

  • 综述了流行的和先进的配体/蛋白质结合动态模拟技术.
  • 对计算药物发现当前挑战的分析.
  • 讨论潜在的解决方案和未来的研究方向.

主要成果:

  • 确定了在动力建模中改进的关键领域:参数化,力场,过渡状态,采样和算法性能.
  • 强调了当前方法论需要进行范式转变的需要.
  • 强调用户友好性和数据开放性对进步至关重要.

结论:

  • 体/蛋白质结合动力学对于预测体内药物疗效至关重要.
  • 需要在计算方法上取得重大进展,以实现准确的运动建模.
  • 未来的努力应集中在改善参数化,采样和算法开发,以加强药物发现.